R
Rachel L. Damico
Researcher at Johns Hopkins University
Publications - 110
Citations - 2155
Rachel L. Damico is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pulmonary hypertension & Internal medicine. The author has an hindex of 23, co-authored 83 publications receiving 1594 citations. Previous affiliations of Rachel L. Damico include Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension
Steven Hsu,Brian A. Houston,Emmanouil Tampakakis,Anita C. Bacher,Parker Rhodes,Stephen C. Mathai,Rachel L. Damico,Todd M. Kolb,Laura K. Hummers,Ami A. Shah,Zsuzsanna H. McMahan,Celia P. Corona-Villalobos,Stefan L. Zimmerman,Fredrick M. Wigley,Paul M. Hassoun,David A. Kass,Ryan J. Tedford +16 more
TL;DR: RV contractile reserve is depressed in SSc-PAH versus IPAH subjects, associated with reduced calcium recycling during exercise, and RV dilation during exercise can predict adverse ventricular-vascular coupling in PAH patients.
Journal ArticleDOI
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Paul M. Hassoun,Roham T. Zamanian,Rachel L. Damico,Noah Lechtzin,Rubina M. Khair,Todd M. Kolb,Ryan J. Tedford,Olivia L. Hulme,Traci Housten,Chiara Pisanello,Takahiro Sato,Erica H. Pullins,Celia P. Corona-Villalobos,Stefan L. Zimmerman,Mohamed A. Gashouta,Omar A. Minai,Fernando Torres,Reda E. Girgis,Kelly Chin,Stephen C. Mathai +19 more
TL;DR: Up-front combination therapy with ambrisentan and tadalafil significantly improved hemodynamics, RV structure and function, and functional status in treatment-naive patients with SSc-PAH and may represent a very effective therapy for this patient population.
Journal ArticleDOI
Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension
Ryan J. Tedford,Claude A. Beaty,Stephen C. Mathai,Todd M. Kolb,Rachel L. Damico,Paul M. Hassoun,Peter J. Leary,David A. Kass,Ashish S. Shah +8 more
TL;DR: This large analysis investigating the prognostic value of DPG found an elevated DPG had no effect on post-transplant survival in patients with PH and an elevated TPG and PVR.
Journal ArticleDOI
Serum Endostatin Is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension
Rachel L. Damico,Todd M. Kolb,Lidenys Valera,Lan Wang,Traci Housten,Ryan J. Tedford,David A. Kass,Nicholas Rafaels,Li Gao,Kathleen C. Barnes,Raymond L. Benza,James L. Rand,Rizwan Hamid,James E. Loyd,Ivan M. Robbins,Anna R. Hemnes,Wendy K. Chung,Eric D. Austin,M. Bradley Drummond,Stephen C. Mathai,Paul M. Hassoun +20 more
TL;DR: Serum ES correlated with poor functional status, decreased exercise tolerance, and invasive hemodynamics variables, and a loss-of-function, missense variant in the gene encoding ES, Col18a1, was linked to lower circulating protein and was independently associated with reduced mortality.
Journal ArticleDOI
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease
Emmanouil Tampakakis,Sanjiv J. Shah,Barry A. Borlaug,Peter J. Leary,Harnish H. Patel,Wayne L. Miller,Benjamin W. Kelemen,Brian A. Houston,Todd M. Kolb,Rachel L. Damico,Stephen C. Mathai,Edward K. Kasper,Paul M. Hassoun,David A. Kass,Ryan J. Tedford,Ryan J. Tedford +15 more
TL;DR: Pulmonary effective arterial elastance and pulmonary arterial compliance more consistently predicted mortality than pulmonary vascular resistance or transpulmonary gradient across a spectrum of left heart disease with pulmonary hypertension, including patients withHeart failure with preserved ejection fraction, heart failure with reduced ejection fractions, and pulmonary hypertension with a normal pulmonary vascular Resistance.